A kind reminder that on Wednesday, July 22, 2026 from 12:00 – 1:00 pm, Dr. Roberto Machado and the Department of Medicine (DOM) are hosting our own Dr. Shella Saint-Fleur Lominy for their Weekly Grand Rounds Seminar. Dr. Saint Fleur-Lominy is an Associate Professor of Medicine, Chair of the Data Safety Monitoring Review Board, and a member of the Program in Oncology (PIO) Cancer Therapeutics Program at the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center. Additionally, she is the founding Co-Leader of UMGCCC’s International Oncology Observership Program and Associate Graduate faculty for the Molecular Medicine Program. Dr. Saint Fleur-Lominy is a physician-scientist specializing in leukemia and myeloid disorders with a research focus on Acute Lymphoblastic Leukemia (ALL). Additional information will be disseminated as we move closer to the event. In-person attendance is preferred, however, you can find a Zoom link immediately below the announcement. We look forward to your attendance and participation. Thank you.
- About
- Administration
- Research Programs
- Clinical Research
- Shared Resources
-
Training & Education
- Middle & High School Programs
- Summer Undergraduate Research Programs
- Post-baccalaureate: STAR-PREP
- Graduate Training & Education
- American Cancer Society Institutional Research Grants
- ARCH K12 Program
- Continuing Medical Education
- Faculty Development
- International Oncology Observership Program
- Predoctoral T32 Training Program in Cancer Biology
- Postdoctoral T32 Training Program in Cancer Biology
- Postdoctoral Training
- Clinical Residency / Fellowship
- Radiation Therapy Training Program
- Steering Committee
- T32 Cancer Biology Training Grant
- Community Outreach
- Funding Opportunities
- Events Calendar
- Newsroom
- Member Resources
Breadcrumb
DOM Grand Rounds Seminar
Venue
Shock Trauma Auditorium (T1R18)
Speaker's Full Name and Affiliation
Shella Saint-Fleur Lominy, MD, PhD, Associate Professor of Medicine, Chair of the Data Safety Monitoring Review Board, and a member of the Program in Oncology (PIO) Cancer Therapeutics Program at UMGCCC
Event Description